NO962403L - Nye syntetiske peptider, lungeoverflateaktivt middel inneholdende samme og middel mot respiratorisk lidelsessyndrom - Google Patents

Nye syntetiske peptider, lungeoverflateaktivt middel inneholdende samme og middel mot respiratorisk lidelsessyndrom

Info

Publication number
NO962403L
NO962403L NO962403A NO962403A NO962403L NO 962403 L NO962403 L NO 962403L NO 962403 A NO962403 A NO 962403A NO 962403 A NO962403 A NO 962403A NO 962403 L NO962403 L NO 962403L
Authority
NO
Norway
Prior art keywords
peptide
respiratory disorder
pulmonary surfactant
disorder syndrome
synthetic peptides
Prior art date
Application number
NO962403A
Other languages
English (en)
Norwegian (no)
Other versions
NO962403D0 (no
Inventor
Tsunetomo Takei
Eiji Ohtsubo
Hirosi Ohkawa
Original Assignee
Tokyo Tanabe Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Tanabe Co filed Critical Tokyo Tanabe Co
Publication of NO962403D0 publication Critical patent/NO962403D0/no
Publication of NO962403L publication Critical patent/NO962403L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
NO962403A 1993-12-08 1996-06-07 Nye syntetiske peptider, lungeoverflateaktivt middel inneholdende samme og middel mot respiratorisk lidelsessyndrom NO962403L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30765793 1993-12-08
PCT/JP1994/002057 WO1995015980A1 (en) 1993-12-08 1994-12-07 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome

Publications (2)

Publication Number Publication Date
NO962403D0 NO962403D0 (no) 1996-06-07
NO962403L true NO962403L (no) 1996-06-07

Family

ID=17971685

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962403A NO962403L (no) 1993-12-08 1996-06-07 Nye syntetiske peptider, lungeoverflateaktivt middel inneholdende samme og middel mot respiratorisk lidelsessyndrom

Country Status (22)

Country Link
US (1) US5827825A (cs)
EP (1) EP0733645B1 (cs)
JP (1) JP3644035B2 (cs)
KR (1) KR100342806B1 (cs)
CN (1) CN1057099C (cs)
AT (1) ATE234865T1 (cs)
AU (1) AU682738B2 (cs)
BG (1) BG62777B1 (cs)
CA (1) CA2178345A1 (cs)
CZ (1) CZ162396A3 (cs)
DE (1) DE69432313T2 (cs)
DK (1) DK0733645T3 (cs)
ES (1) ES2189825T3 (cs)
FI (1) FI962355L (cs)
HU (1) HU215933B (cs)
NO (1) NO962403L (cs)
NZ (1) NZ277095A (cs)
PL (1) PL180020B1 (cs)
PT (1) PT733645E (cs)
RO (1) RO118298B1 (cs)
SK (1) SK71496A3 (cs)
WO (1) WO1995015980A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017872A1 (en) * 1994-12-07 1996-06-13 Tokyo Tanabe Company Limited Intermediate for producing surfactant peptide
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
JPH11217397A (ja) * 1997-11-27 1999-08-10 Saburo Aimoto ペプチドチオールエステルの製造方法
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
BR9906091A (pt) * 1999-12-22 2002-06-04 Conselho Nacional Cnpq Usos de resina de troca aniÈnica (epm-7) como suporte sólido para a sìntese peptìdica e para cromatografia de afinidade
US6998384B2 (en) 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
ATE376556T1 (de) * 2003-12-31 2007-11-15 Hoffmann La Roche Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
AU2005247319B2 (en) * 2004-04-28 2011-12-01 Molecules For Health, Inc. Methods for treating or preventing restenosis and other vascular proliferative disorders
JPWO2005105111A1 (ja) * 2004-04-29 2008-07-31 相男 李 人工肺サーファクタント組成物およびその使用方法
KR100635541B1 (ko) * 2004-10-12 2006-10-18 경북대학교 산학협력단 신규한 염증성 질환의 예방 또는 치료용 약학적 조성물
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
EP2298349A1 (en) 2005-01-06 2011-03-23 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
WO2007084136A2 (en) * 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
WO2008036293A1 (en) * 2006-09-19 2008-03-27 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
JP5473899B2 (ja) 2008-04-02 2014-04-16 国立大学法人徳島大学 合成ペプチドを含有する抗原薬物ビークルとこれを用いる粘膜ワクチン
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290516A4 (en) * 1986-10-24 1989-11-14 Jeffrey A Whitsett PROTEINS RELATED TO SURFACE-EFFECTIVE HYDROPHOBIC LUNG ACTIVE SUBSTANCES.
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
ATE163013T1 (de) * 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤

Also Published As

Publication number Publication date
CA2178345A1 (en) 1995-06-15
NZ277095A (en) 1997-09-22
SK71496A3 (en) 1996-11-06
KR960706507A (ko) 1996-12-09
JP3644035B2 (ja) 2005-04-27
US5827825A (en) 1998-10-27
RO118298B1 (ro) 2003-04-30
EP0733645A1 (en) 1996-09-25
HUT74880A (en) 1997-02-28
FI962355A0 (fi) 1996-06-06
PL180020B1 (en) 2000-12-29
PT733645E (pt) 2003-07-31
DE69432313T2 (de) 2003-10-16
FI962355A7 (fi) 1996-06-06
HU215933B (hu) 1999-03-29
CZ162396A3 (en) 1996-10-16
AU682738B2 (en) 1997-10-16
BG62777B1 (bg) 2000-07-31
NO962403D0 (no) 1996-06-07
KR100342806B1 (ko) 2002-11-29
ES2189825T3 (es) 2003-07-16
AU1199295A (en) 1995-06-27
DK0733645T3 (da) 2003-07-14
CN1136813A (zh) 1996-11-27
DE69432313D1 (de) 2003-04-24
PL314872A1 (en) 1996-09-30
ATE234865T1 (de) 2003-04-15
WO1995015980A1 (en) 1995-06-15
FI962355L (fi) 1996-06-06
EP0733645B1 (en) 2003-03-19
CN1057099C (zh) 2000-10-04
HU9601563D0 (en) 1996-08-28
BG100554A (bg) 1996-12-31
EP0733645A4 (en) 1998-12-09

Similar Documents

Publication Publication Date Title
DE69432313D1 (de) Neuartiges sythetisches Peptil, diese enthaltende Zusammensetzung und Arznei-Zusammensetzung und Arznei gegen das Atemnotsyndrom
ATE162549T1 (de) Epitheline: neue cystein-reiche, den wachstum modulierende proteine
MY100194A (en) Liquid shampoo composition
ES2052947T3 (es) Nueva forma unitaria, solida y porosa que comprende microparticulas y/o nanoparticulas asi como su preparacion.
MY103943A (en) Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical compositions containing it
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
ES2125000T3 (es) Nuevas mezclas terapeuticas de hidratos de carbono utiles para ayudar en el sindrome premenstrual.
JPH0454645B2 (cs)
CA2037715A1 (en) Rigid foams using blends of chlorofluorocarbons and hydrocarbons as blowing agent
DK0651614T3 (da) Stabiliseret fødevaresammensætning
KR890000515A (ko) 식욕억제용 콜레시스토키닌 동족체
Persson Nitrous oxide hypalgesia in man; pain threshold determinations of the tooth with special reference to the role of oxygen lack and oxygen excess, arterial oxygen saturation, concentration of blood gases and application to operative dentistry
JPS6483012A (en) Hair growth agent
ES2063455T3 (es) Nueva forma unitaria, solida y porosa que comprende particulas en forma de perlas asi como su preparacion.
GB928467A (en) Improvements in or relating to venturi scrubbers
陈中瑞 et al. CLINICAL OBSERVATION AND EXPERIMENTAL STUDY ON 300 ANORECTIC CHILDREN TREATED WITH STOMACHIC GRANULES
Tricarico et al. Effects of creatin phosphate l-arginine salt pretreatment on the electrical parameters of ischaemic-reperfused rat skeletal muscle fibres
Huh et al. The Effect of Hydrogen Peroxide-Treated Metallothionein on the Hepatic Xanthine Oxidase Activity
JPS649916A (en) Shampoo composition
GB637973A (en) Improvements in or relating to bath seats and the like
Gurskaia et al. Recovery of impaired respiratory activity in cats by thyroliberin analog (PR-546) devoid of hormonal properties
ATE283341T1 (de) Teppichreinigungspulver mit einer aktivsauerstoffquelle
REICHARDT ARTIST IN SPACE
PE16198A1 (es) Compuesto de ciclohexapeptidil bis-amina, composiciones que lo contienen y metodos de uso
Shayiq et al. Effect of fluoride on the absorption of D-glucose and L-leucine in rats.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application